Not Found: wait
 

News

  • 9/2019: Download GLA-Newsletter 02/2019
  • 1/2019: Download GLA-Newsletter 01/2019
  • 8/2018: Consensus statement of the GLA, DGHO and DAB-KBT for the Allogeneic Stem Cell Transplantation for patients with aggressive lymphoma submitted to the IQWiG
  • 8/2018: 200 Patients randomized in the ECWM-1 trial for the first-line treatment of Waldenstrom Macroglobulinemia (Contact person: Prof. Dr. C. Buske)
  • 8/2018: OLYMP-1 trial for the first-line treatment with Obinutuzumab monotherapy will start in August in Germany (Contact person: Prof. Dr. C. Buske)
  • 7/2018: New ESMO guidelines for Waldenstrom Macroglobulinemia published (Contact person: Prof. Dr. C. Buske)
  • 7/2018: Study results of the innovate trial for the treatment of Waldenstroems Macroglobulinemia with Ibrutinib/Rituximab published in the New England Journal (Contact person: Prof. Dr. C. Buske)
  • 7/2018: European Triangle Study for younger patients with Mantle Cell Lymphoma hits planned recruited rate: 232 patients already recruited in July 2018. (Contact person: Prof. Dr. M. Dreyling)
  • 6/2018: MCL Elderly Study for treatment of elderly patients with Mantle Cell Lymphoma with over 400 recruited patients.